Trials
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
193,990 genes from NCBI Gene.
Most papers first2,221 to 2,240 of 193,990
| Gene | NCBI Gene | Proteins | Patents | Drugs | Trials | NIH grants | Papers |
|---|---|---|---|---|---|---|---|
| DAG1 dystroglycan 1 | 1605 HGNC:2666 | 1 | 98 | 0 | 0 | 1,759 | 2,908 |
| IARS1 isoleucyl-tRNA synthetase 1 | 3376 HGNC:5330 | 1 | 18 | 0 | 0 | 1,644 | 2,904 |
| MAL mal, T cell differentiation protein (MAL blood group) | 4118 HGNC:6817 | 1 | 52 | 0 | 0 | 1,714 | 2,902 |
| SNRNP70 small nuclear ribonucleoprotein U1 subunit 70 | 6625 HGNC:11150 | 1 | 61 | 0 | 0 | 1,378 | 2,902 |
| ERCC5 ERCC excision repair 5, endonuclease | 2073 HGNC:3437 | 1 | 23 | 0 | 0 | 1,600 | 2,901 |
| BIN1 bridging integrator 1 | 274 HGNC:1052 | 1 | 41 | 0 | 0 | 2,709 | 2,900 |
| FBL fibrillarin rRNA 2'-O-methyltransferase | 2091 HGNC:3599 | 1 | 28 | 0 | 0 | 1,725 | 2,899 |
| LPO lactoperoxidase | 4025 HGNC:6678 | 1 | 30 | 0 | 0 | 1,050 | 2,897 |
| CLDN3 claudin 3 | 1365 HGNC:2045 | 1 | 157 | 0 | 0 | 1,332 | 2,896 |
| MIR429 microRNA 429 | 554210 HGNC:13784 | 0 | 0 | 0 | 0 | 924 | 2,894 |
| GZMK granzyme K | 3003 HGNC:4711 | 1 | 87 | 0 | 0 | 2,103 | 2,892 |
| TBX5 T-box transcription factor 5 | 6910 HGNC:11604 | 1 | 54 | 0 | 0 | 2,537 | 2,892 |
| CRTC1 CREB regulated transcription coactivator 1 | 23373 HGNC:16062 | 1 | 15 | 0 | 0 | 2,107 | 2,891 |
| CTBP1 C-terminal binding protein 1 | 1487 HGNC:2494 | 1 | 48 | 0 | 0 | 2,062 | 2,891 |
| FCER1G Fc epsilon receptor Ig | 2207 HGNC:3611 | 1 | 269 | 0 | 0 | 2,108 | 2,891 |
| GSK3A glycogen synthase kinase 3 alpha | 2931 HGNC:4616 | 1 | 67 | 5 | 90 | 2,118 | 2,889 |
| NAPSA napsin A aspartic peptidase | 9476 HGNC:13395 | 1 | 60 | 0 | 0 | 618 | 2,888 |
| HDAC5 histone deacetylase 5 | 10014 HGNC:14068 | 1 | 8 | 12 | 389 | 1,955 | 2,885 |
| SMC1A structural maintenance of chromosomes 1A | 8243 HGNC:11111 | 1 | 37 | 0 | 0 | 2,173 | 2,883 |
| SOX1 SRY-box transcription factor 1 | 6656 HGNC:11189 | 1 | 38 | 0 | 0 | 1,617 | 2,883 |
Code
curl "https://conductscience.org/api/genes/v1?page=112"
Response
The first 2 of this page's 20 results. GET /api/genes/v1?page=112
{
"data": {
"total": 193990,
"results": [
{
"id": "1605",
"title": "DAG1: dystroglycan 1",
"summary": "NCBI Gene 1605. 1 protein, 98 patents, 0 drugs, 0 trials, 1,759 NIH grants and 2,908 papers.",
"record": "/library/genes/1605",
"gene_id": 1605,
"symbol": "DAG1",
"name": "dystroglycan 1",
"hgnc_id": "HGNC:2666",
"counts": {
"proteins": 1,
"patents": 98,
"drugs": 0,
"trials": 0,
"grants": 1759,
"papers": 2908
}
},
{
"id": "3376",
"title": "IARS1: isoleucyl-tRNA synthetase 1",
"summary": "NCBI Gene 3376. 1 protein, 18 patents, 0 drugs, 0 trials, 1,644 NIH grants and 2,904 papers.",
"record": "/library/genes/3376",
"gene_id": 3376,
"symbol": "IARS1",
"name": "isoleucyl-tRNA synthetase 1",
"hgnc_id": "HGNC:5330",
"counts": {
"proteins": 1,
"patents": 18,
"drugs": 0,
"trials": 0,
"grants": 1644,
"papers": 2904
}
}
],
"columns": [
{
"key": "symbol",
"label": "Gene",
"under": "name"
},
{
"key": "id",
"label": "NCBI Gene",
"under": "hgnc_id"
},
{
"key": "counts.proteins",
"label": "Proteins"
},
{
"key": "counts.patents",
"label": "Patents"
},
{
"key": "counts.drugs",
"label": "Drugs"
},
{
"key": "counts.trials",
"label": "Trials"
},
{
"key": "counts.grants",
"label": "NIH grants"
},
{
"key": "counts.papers",
"label": "Papers"
}
],
"order": "Most papers first"
},
"release": "gene-search-2026-11-11-0.2.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ChEMBL, through Open Targets",
"license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC BY-SA 3.0"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "No license stated"
},
{
"source": "EMBL-EBI's patent proteins",
"license": "EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: \"EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners\" and \"EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools.\" Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use",
"notice": null,
"short": "No added restrictions. Attribution expected"
},
{
"source": "GenBank's patent files",
"license": "GenBank's patent files. NCBI: \"NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted.\" Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/",
"notice": null,
"short": "No restrictions from NCBI. Submitters may hold rights"
},
{
"source": "HGNC",
"license": "CC0: https://www.genenames.org/about/license/",
"notice": null,
"short": "CC0"
},
{
"source": "NCBI Gene",
"license": "None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/",
"notice": null,
"short": "Public domain (US government)"
},
{
"source": "NIH's project files and grant-paper links",
"license": "Public domain (NIH RePORTER)",
"notice": null,
"short": "Public domain"
},
{
"source": "Open Targets",
"license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC0 1.0"
},
{
"source": "PubMed",
"license": "NLM's terms",
"notice": null,
"short": "NLM's terms"
},
{
"source": "PubTator 3",
"license": "Public domain",
"notice": null,
"short": "Public domain"
},
{
"source": "UniProt",
"license": "CC BY 4.0. UniProt's licence file: \"All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy.\" UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license",
"notice": null,
"short": "CC BY 4.0"
}
],
"next": "/api/genes/v1?page=113",
"request_id": "5z4VSiB5p7mQ_iY7"
}Ask about these results. The first 10 go in the prompt.
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
ClinicalTrials.gov
Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.
Patent publications
Paste a sequence and see the patents that disclose it.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/genes/v1. No key.
GET https://conductscience.org/api/genes/v1?q=p53
Ask an assistant